Home » Topics » Regulatory » Patents

Patents
RSS

Bristol-Myers Squibb presents apelin receptor agonists

Dec. 23, 2016

Chiesi Farmaceutici develops PDE4B inhibitors and/or muscarinic M3 receptor antagonists

Dec. 23, 2016

GemVax & KAEL patent TNF-alpha production inhibitors and TGF-beta inhibitors

Dec. 23, 2016

Chinese scientists develop CDK/cyclin inhibitors

Dec. 22, 2016

Orion describes alpha2C-adrenoceptor antagonists

Dec. 22, 2016

Merck & Co. discloses BTK inhibitors

Dec. 22, 2016

Merck & Co. and SD R&D patent PDE2 inhibitors

Dec. 22, 2016

Jiangsu Tasly Diyi Pharmaceutical presents antiviral agents

Dec. 21, 2016

Teijin Pharma develops CDK4/cyclin D3 and CDK6/cyclin D3 inhibitors

Dec. 21, 2016

Rugen Holdings describes NR2B receptor antagonists

Dec. 21, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...